PD-1/PD-L1 inhibitor
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for PD-1/PD-L1 inhibitor, covering 2020-03-18 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors [Phase 1]